Post by
palinc2000 on Feb 16, 2023 4:53pm
February 28 th PR and CC
We now know that the late date is not related to expectations of getting an FDA ok for an amendment of the protocol in Phase 1 for TH 190 as some suggested.
Why then such a late date?
1--Maybe due to more time needed to finalise year end Financial Statements...Possible but unlikely imo
2-Waiting till the last minute to be able to pre announce First Quarter revenues ...hopefully to the upside but idk
3- Maybe they are in the midst ofnegotiating a deal in Nash with a parner and they are hoping to be able to make an announcement prior to Feb 28
Not predicting anything but there is a reason for the delay and cant think of anything outside of the above
Comment by
muslix1 on Feb 16, 2023 5:11pm
Palnic i like your crytal ball...lol
Comment by
SABBOBCAT on Feb 16, 2023 5:53pm
I was scratching my head on this as well. I am not surprised by the delay, but why? Also why announce the revised TH1902 timeline now vs. During the business update? Time will tell.
Comment by
Trogarzon on Feb 16, 2023 9:34pm
We need a good break.. we need a deal, a partnership, something with a pharma we actually recognize the name, not some kind of second line biotech player.. a good partner and a good upfront. We need that.